Gastric cardia adenocarcinoma pathway analysis

Gastroenterology and Hepatology from Bed to Bench

Volumn 6, Issue SUPPL., 2013, Pages

  Zali, Hakimeh ^a   Rezaei Tavirani, Mostafa ^b   Vafaee, Reza ^b   Rezaei Tavirani, Majid ^c  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ILAM UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Biomarker; Gastric cardia adenocarcinoma; Pathway

Indexed keywords

DNA; PROTEIN P53; TOLL LIKE RECEPTOR; TUMOR MARKER;

BREAST CANCER; CANCER CELL; CANCER INCIDENCE; CELL CYCLE; COLORECTAL CANCER; DNA REPLICATION; DOWN REGULATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE SILENCING; HELICOBACTER INFECTION; HUMAN; LUNG SMALL CELL CANCER; MUTATION; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION; STOMACH ADENOCARCINOMA; TUMOR GENE; UPREGULATION;

EID: 84888811199     PISSN: 20082258     EISSN: 20084234     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. Bruckner HW, Morris JC, Mansfield P. Neoplasms of the stomach. In: Bast RC, Kufe DW, Pollock RE, Weichselbaum RR, Holland JF, Frei E, III, et al. editors. Cancer Medicine, 5th ed. Ontario, British Columbia: Decker Inc; 2000.
2. Ling XL, Fang DC, Wang RQ, Yang SM, Fang L. Mitochondrial microsatellite instability in gastric cancer and its procancerous lesions. World J Gastroenterol 2004;10:800-803.
3. Sugano K. Gastric cancer: pathogenesis, screening, and treatment. Gastrointest Endosc Clin N Am 2008;18:513-22.
4. di Mario F, Cavallaro LG. Non-invasive tests in gastric diseases. Dig Liver Dis 2008;40:523-30.
5. Opocher E, Santambrogio R, Bianchi P, CioffiU, De Simone M, Vellini S, Montorsi M. Isolated splenic metastasis from gastric carcinoma: value of CEA and CA 19-9 in early diagnosis: report of two cases. Am J Clin Oncol 2000;23:579-80.
6. Park WS, Oh RR, Park JY, Lee SH, Shin MS, Kim HS, et al. Frequent somatic mutations of the betacatenin gene in intestinal-type gastric cancer. Cancer Res1999;59: 4257-60.
7. Gleeson CM, Sloan JM, McManus DT, Maxwell P, Arthur K, McGuigan JA, et al. Comparison of p53 and DNA content abnormalities in adenocarcinoma of theoesophagus and gastric cardia. Br J Cancer 1998;77: 277-86.
8. Berx G, Becker KF, Hofler H, van RF. Mutations of the human Ecadherin (CDH1) gene. Hum Mutat 1998;12: 226-37.
9. Park WS, Oh RR, Park JY, Lee JH, Shin MS, Kim HS, et al. Somatic mutations of the trefoil factor family 1 gene in gastric cancer. Gastroenterology 2000;119: 691-98.
10. Lee JH, Han SU, Cho H, Jennings B, Gerrard B. A novel germ line juxta membrane Met mutation in human gastric cancer. Oncogene 2000;19: 4947-53.
11. Suzuki T, Yasui W, Yokozaki H, Naka K, Ishikawa T, Tahara E. Expression of the E2F family inhuman gastrointestinal carcinomas. Int J Cancer 1999; 81:535-38.
12. Cheng XX, Wang ZC, Chen XY, Sun Y, Kong QY, Liu J, et al. Frequent loss of membranous E-cadherin in gastric cancers: a cross-talk with Wnt in determining the fate of beta catenin. Clin Exp Metastasis 2005; 22:85-93.
13. Tytgat GN, Bartelink H, Bernards R, Giaccone G, van Lanschot JJ, Offerhaus GJ, et al. Cancer of the esophagus and gastric cardia: recent advances. Dis Esophagus 2004;17:10-26.
14. Tajima Y, Nakanishi Y, Yoshino T, Kokawa A, Kusano M, Shimoda T. Clinicopathological study of early adenocarcinoma of the gastric cardia:comparison with early adenocarcinoma of the distal stomach and esophagus. Oncology 2001;61: 1-9.
15. Babaei M, Pourfarzi F, Yazdanbod A, Chiniforush MM, Derakhshan MH, MousaviSM, et al. Gastric Cancer in Ardabil, Iran - a Review and Update onCancer Registry Data. Asian Pacific J Cancer Prev 2010;11: 595-99.
16. Gao Y, Hu N, Han XY, Ding T, Giffen C, Goldstein AM, et al. Risk factors foresophagel and gastric cancers in Shanxi Province, China: A casecontrol study. Cancer Epidemiol 2011;35: 91-99.
17. Anderson WF, Camargo MC, Fraumeni JF Jr, Correa P, Rosenberg PS, Rabkin CS. Age-specific trends in incidence of noncardia gastric cancer in US adults. JAMA 2010;303: 1723-28.
18. Li JY, Taylor PR, Li B, Dawsey S, Wang GQ, Ershow AG, et al. Nutrition intervention trials in Linxian, China: multiple vitamin/mineral supplementation, cancer incidence, and disease-specific mortality among adults with esophageal dysplasia. J Natl Cancer Inst 1993;85: 1492-98.
19. Mark SD, Qiao YL, Dawsey SM, Wu YP, Katki H, Gunter EW, et al. Prospective study of serum selenium levels and incident esophageal and gastric cancers. J Natl Cancer Inst 2000;92: 1753-63.
20. Wei W, Abnet CC, Qiao YL, Dawsey SM, Dong ZW, Sun XD, et al. Prospective study of serum selenium concentration and esophageal and gastric cardiacancer, heart disease, stroke, and total death. Am J Clin Nutr 2004;79: 80-85.
21. Gao Y, Hu N, Han X, Giffen C, Ding T, Goldstein A, et al. Family history of cancer and risk for esophageal and gastric cancer in Shanxi, China. BMC Cancer 2009;9:269.
22. Sipponen P. Helicobacter pylori: a cohort phenomenon. Am J SurgPathol 1995;1: S30-36.
23. Tran GD, Sun XD, Abnet CC, Fan JH, Dawsey SM, Dong ZW, et al. Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China. Int J Cancer 2005;113: 456-63.
24. Kamangar F, Qiao YL, Blaser MJ, Sun XD, Katki H, Fan JH, et al. Helicobacter pylori and oesophageal and gastric cancers in a prospective study in China. Br J Cancer 2007;96: 172-76.
25. Wang G, Hu N, Yang HH, Wang L, Su H, Wang C, et al. Comparison of global gene expression of gastric cardia and noncardia cancers from a high-risk population in China. PLoS ONE 2013;8: 63826.
26. Huang W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009; 4: 44-57.
27. Bergmann S, Ihmels J, Barkai N. Similarities and differences in genome-wide expression data of six organisms. PLoS Biol 2004; 2: 9.
28. Stuart JM, Segal E, Koller D, Kim SK. A gene coexpression network for global discovery of conserved genetic modules. Science 2003; 302: 249-55.
29. Abnet CC, Freedman ND, Hu N, Wang Z, Yu K, Shu XO, et al. A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma. Nat Genet 2010;42: 764-67.
30. Derakhshan MH, Yazdanbod A, Sadjadi AR, Shokoohi B, McColl KE, Malekzadeh R. High incidence of adenocarcinoma arising from the right side of the gastric cardia in NW Iran. Gut 2004;53, 1262-66.
31. Malekzadeh R, Sotoudeh V, Derakhshan MH, Mikaeli J, Yazdanbod A, Merat S, et al. Prevalence of gastric precancerous lesions in Ardabil, a high incidence province for gastric adenocarcinoma in the north west of Iran. J Clin Pathol 2004;57:37-42.
32. Jinawath N, Furukawa Y, Hasegawa S, Li M, Tsunoda T, Satoh S, et al. Comparison of geneexpression profiles between diffuse- and intestinal-type gastric cancers using a genome-wide cDNA microarray. Oncogene 2004;23: 6830-44.
33. Boussioutas A, Li H, Liu J, Waring P, Lade S, Holloway AJ, et al. Distinctive patterns of gene expression in premalignant gastric mucosa and gastric cancer. Cancer Res 2003;63: 2569-77.
34. Chen X, Leung SY, Yuen ST, Chu KM, Ji J, Li R, et al. Variation in gene expression patterns in human gastric cancers. Mol Biol Cell 2003;14: 3208-15.
35. Rio FT, Lavoie J, Hamel N, Geyer FC, Kushner YB, Novak DJ, et al. HomozygousBUB1B mutation and susceptibility to gastrointestinal neoplasia. N Engl J Med 2010;363: 2628-37.
36. Furuyama K, Kawaguchi Y, Akiyama H, Horiguchi M, Kodama S, Kuhara T, et al. Continuous cell supply from a Sox9-expressing progenitor zone in adult liver, exocrine pancreas and intestine. Nat Genet 2011;43: 34-41.
37. Hasegawa S, Furukawa Y, Li M, Satoh S, Kato T, Watanabe T, et al. Genome-wide analysis of gene expression in intestinal-type gastric cancers using acomplementary DNA microarray representing 23,040 genes. Cancer Res 2002;62:7012-17.
38. Kim B, Bang S, Lee S, Kim S, Jung Y, Lee C, et al. Expression profiling and subtype-specific expression of stomach cancer. Cancer Res 2003;63: 8248-55.
39. Lee M, Liu M, Lee C. Gene therapy for prostate cancer targeting transcription factor E2F/DRTF. Int J Oncol 1997;10:729-34.
40. Rabbani F, Richon VM, Orlow I, Lu ML, Drobnjak M, Dudas M, et al. Prognostic significance of transcription factor E2F-1 in bladder cancer: genotypic and phenotypic characterization. J Natl Cancer Inst 1999; 91: 874-81.
41. Tsukasaki K, Miller CW, Greenspun E, Eshaghian S, Kawabata H, FujimotoT, et al. Mutations in the mitotic check point gene, MAD1L1, in human cancers. Oncogene 2001;20: 3301-305.
42. Oxana M. Down regulation of Rap1GAP in human tumor cells alters cell/matrix and cell/cell adhesion. Mol Cell Biol 2010; 30: 3262-74.
43. Giordano J, Prior HM, Bamforth JS, Walter MA. Genetic study of SOX9 in a case of campomelic dysplasia. Am J Med Genet 2001;98:176-81.
44. Buchbinder D, Puthenveetil G, Soni A, Hsieh L, Nugent D, Church JA. Newborn screening for severe combined immunodeficiency: an opportunity for intervention. J Perinatol 2013;33:657-58.
45. Li Z, He X, Xing S, Ni J, Zhang W, Xu X, et al. Overexpression of Aldo-keto reductase family 1 B10 protein in ductal carcinoma in situ of the breast correlates with HER2 positivity. Cancer Biomark 2013;13:181-92.